FIELD: biotechnology.
SUBSTANCE: invention relates to biotechnology, specifically to recombinant production of therapeutic proteins, and can be used to produce human recombinant follicle-stimulating hormone (rhFSH). Plasmid expression vectors pTVK4p-FSHalpha and pTVK4n-FSHbeta are constructed, containing codon-optimized genes of alpha and beta subunit follicle-stimulating human hormone respectively. Said vectors are transformed CHO cells to produce cell line CHO-FSH 91 – producer rhFSH, which is used in production method rhFSH.
EFFECT: invention allows to increase production FSH human being for medical use.
4 cl, 9 dwg, 2 tbl, 7 ex
Authors
Dates
2019-08-13—Published
2019-02-22—Filed